Related content

PECAM-1 is involved in BCR/ABL signaling and may downregulate imatinib-induced apoptosis of Philadelphia chromosome-positive leukemia cells

By          

International Journal of Oncology, Vol. 42, Iss. 2, 2013-01 ,pp. : 419-428

Spandidos Publications

Access to resources Recommend Favorite

Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate

By Hardling Mats   Wei Yuan   Palmqvist Lars   Swolin Birgitta   Stockelberg Dick   Gustavsson Bengt   Ekeland-Sjöberg Kerstin   Wadenvik Hans   Ricksten Anne  

Medical Oncology, Vol. 21, Iss. 4, 2004-12 ,pp. : 349-358

Humana Press, Inc

Access to resources Recommend Favorite

Apoptotic Effects of Some Tetrahydronaphthalene Derivatives on K562 Human Chronic Myelogenous Leukemia Cell Line

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 14, 2018-02 ,pp. : 1924-1930

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple copies of BCR-ABL fusion gene on two isodicentric Philadelphia chromosomes in an imatinib mesylateresistant chronic myeloid leukemia patient

By          

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1579-1582

Spandidos Publications

Access to resources Recommend Favorite

Chronic myelomonocytic leukemia with p190 BCR-ABL rearrangement mimicking advanced liver disease at presentation

By Alagiozian-Angelova Victoria   Kadkol Shrihari   Lindgren Valerie   Peace David   Gaitonde Sujata  

Acta Oncologica, Vol. 46, Iss. 4, 2007-01 ,pp. : 554-556

Informa Healthcare

Access to resources Recommend Favorite